ESR1 and neoplasm: As correlations in the screening and randomised patient cohorts implied that YAP1 behaves differently depending on the tumours’ expression of ER, recurrence-free survival was analysed in ER+ and ER- subgroups of the gene expression dataset (Figure 2b and c).